Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis
Eduardo Mysler, Mariana Caubet, Ana Lizarraga Organización Medica de Investigación, Buenos Aires, ArgentinaCorrespondence: Eduardo Mysler Email e.mysler@omiargentina.com.arAbstract: Rheumatoid arthritis (RA) is the most prevalent form of inflammatory arthritis. It is a profound...
Saved in:
Main Authors: | Mysler E, Caubet M, Lizarraga A |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/45b1d4dc816145d7b84c99f4c59ddaae |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of rheumatoid arthritis during pregnancy: challenges and solutions
by: Krause ML, et al.
Published: (2016) -
Patterns of Response to Different Treatment Strategies in Seropositive Rheumatoid Arthritis Patients in a Tertiary Hospital in South‐Western Saudi Arabia: A Retrospective Study
by: AlOmair M, et al.
Published: (2021) -
Improvement of HbA1c in Patients with Type 2 Diabetes Mellitus and Rheumatoid Arthritis Treated with bDMARDs
by: Lurati A, et al.
Published: (2021) -
Tuberculosis Arthritis in the Wrist While Using Rituximab for Rheumatoid Arthritis Treatment
by: Ulusoy H, et al.
Published: (2020) -
The onset of rheumatoid arthritis following trauma
by: Brawer AE, et al.
Published: (2016)